[1] |
MITCHELL E, GILBERT M, LOOMES K M. Alagille syndrome[J]. Clin Liver Dis, 2018, 22(4): 625-641. doi: 10.1016/j.cld.2018.06.001
|
[2] |
武丽娜, 孙丽莹, 朱志军, 等. Alagille综合征的临床及病理特征分析[J]. 肝脏, 2023, 28(3): 351-354, 363. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN202303022.htmWU L N, SUN L Y, ZHU Z J, et al. Clinical and histological characteristics of patients with Alagille syndrome[J]. Chinese Hepatology, 2023, 28(3): 351-354, 363. https://www.cnki.com.cn/Article/CJFDTOTAL-ZUAN202303022.htm
|
[3] |
SHIVARAM P S, GIRISH K P. Alagille syndrome and the liver: current insights[J]. Euroasian J Hepatogastroenterol, 2018, 8(2): 140-147.
|
[4] |
卫慧静, 刘攀, 彭晓康, 等. 一个Alagille综合征家系的JAG1基因新变异与临床表型分析[J]. 中华医学遗传学杂志, 2021, 38(6): 545-548. doi: 10.3760/cma.j.cn511374-20200410-00249WEI H J, LIU P, PENG X K, et al. Analysis of a novel JAG1 variant and clinical phenotype in a family affected with Alagille syndrome[J]. Chinese Journal of Medical Genetics, 2021, 38(6): 545-548. doi: 10.3760/cma.j.cn511374-20200410-00249
|
[5] |
SEYMOUR P A, COLLIN C A, EGESKOV-MADSEN A R, et al. JAG1 modulates an oscillatory Dll1-Notch-Hes1 signaling module to coordinate growth and fate of pancreatic progenitors[J]. Dev Cell, 2020, 52(6): 731-747. doi: 10.1016/j.devcel.2020.01.015
|
[6] |
KOHUT T J, GILBERT M A, LOOMES K M. Alagille syndrome: a focused review on clinical features, genetics, and treatment[J]. Semin Liver Dis, 2021, 41(4): 525-537. doi: 10.1055/s-0041-1730951
|
[7] |
李红, 周俪姗, 王芳, 等. Alagille综合征临床病理及基因突变特征分析1例[J]. 华中科技大学学报(医学版), 2021, 50(2): 230-233. doi: 10.3870/j.issn.1672-0741.2021.02.017LI H, ZHOU L S, WANG F, et al. Clinicopathological and gene mutation characteristics of Alagille syndrome: a case report[J]. Acta Med Univ Sci Technol Huazhong, 2021, 50(2): 230-233. doi: 10.3870/j.issn.1672-0741.2021.02.017
|
[8] |
NIKNEJAD N, FOX D, BURWINKEL J L, et al. ASO silencing of a glycosyltransferase, Poglut1, improves the liver phenotypes in mouse models of Alagille syndrome[J]. Hepatology, 2023, 78(5): 1337-1351. doi: 10.1097/HEP.0000000000000380
|
[9] |
郭丽, 赵书涛, 程映, 等. Alagille综合征患儿11例临床和遗传学分析[J]. 中华儿科杂志, 2018, 56(5): 353-358. doi: 10.3760/cma.j.issn.0578-1310.2018.05.009GUO L, ZHAO S T, CHENG Y, et al. Clinical and genetic analysis of eleven pediatric patients with Alagille syndrome[J]. Chinese Journal of Pediatrics, 2018, 56(5): 353-358. doi: 10.3760/cma.j.issn.0578-1310.2018.05.009
|
[10] |
陈玉霞, 詹学, 李蜀媛. Alagille综合征13例患儿特征分析[J]. 中华实用儿科临床杂志, 2020, 35(19): 1468-1471. doi: 10.3760/cma.j.cn101070-20190520-00432CHEN Y X, ZHAN X, LI S Y. Characteristic analysis of 13 children with Alagille syndrome[J]. Chin J Appl Clin Pediatr, 2020, 35(19): 1468-1471. doi: 10.3760/cma.j.cn101070-20190520-00432
|
[11] |
BREIKAA R M, DENMAN K, UEYAMA Y, et al. Loss of Jagged1 in mature endothelial cells causes vascular dysfunction with alterations in smooth muscle phenotypes[J]. Vascul Pharmacol, 2022, 145: 107087. DOI: 10.1016/j.vph.2022.107087.
|
[12] |
GUO Q, HUANG F, QING Y, et al. Decreased Jagged1 expression in vascular smooth muscle cells delays endothelial regeneration in arteriovenous graft[J]. Cardiovasc Res, 2020, 116(13): 2142-2155. doi: 10.1093/cvr/cvz333
|
[13] |
CHEN Y, LIU Y, ZHANG R, et al. Delta like non-canonical notch ligand 2 inhibits chondrogenic differentiation and cell proliferation of bone marrow mesenchymal stem cells through the notch1 signaling pathway[J]. Tissue Cell, 2023, 85: 102220. DOI: 10.1016/j.tice.2023.102220.
|
[14] |
KRIEGERMEIER A, GREEN R. Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies[J]. Front Med(Lausanne), 2020, 7: 149. DOI: 10.3389/fmed.2020.00149.
|
[15] |
张东矗, 邓敦, 童郁, 等. 慢性乙肝患者伴骨质疏松症的危险因素研究[J]. 中华全科医学, 2020, 18(3): 432-434, 445. doi: 10.16766/j.cnki.issn.1674-4152.001265ZHANG D C, DENG D, TONG Y, et al. The research of risk factors in chronic hepatitis B patients with osteoporosis[J]. Chinese Journal of General Practice, 2020, 18(3): 432-434, 445. doi: 10.16766/j.cnki.issn.1674-4152.001265
|
[16] |
MUNTAHA H S T, MUNIR M, SAJID S H, et al. Ileal bile acid transporter blockers for cholestatic liver disease in pediatric patients with Alagille syndrome: a systematic review and meta-analysis[J]. J Clin Med, 2022, 11(24): 7526. DOI: 10.3390/jcm11247526.
|
[17] |
陈琳洁, 李志军. 原发性骨质疏松症诊断与治疗[J]. 中华全科医学, 2020, 18(10): 1619-1620. http://www.zhqkyx.net/article/id/5c756c38-3de0-43c5-af82-69be383bf5b2CHEN L J, LI Z J. Diagnosis and treatment of primary osteoporosis[J]. Chinese Journal of General Practice, 2020, 18(10): 1619-1620. http://www.zhqkyx.net/article/id/5c756c38-3de0-43c5-af82-69be383bf5b2
|
[18] |
闵晓阳, 张亚男, 马毓梅, 等. Alagille综合征的临床特征及基因突变观察(附2例报告)[J]. 山东医药, 2020, 60(18): 17-20. doi: 10.3969/j.issn.1002-266X.2020.18.005MIN X Y, ZHANG Y N, MA Y M, et al. Clinical features and gene mutations of Alagille syndrome (report of 2 cases)[J]. Shandong Medical Journal, 2020, 60(18): 17-20. doi: 10.3969/j.issn.1002-266X.2020.18.005
|